(PRESS RELEASE) ZÜRICH, 8-Dec-2021 — /EuropaWire/ — Credit Suisse, a global wealth manager, investment bank and financial services firm, has announced the publication of its study on the Swiss office property market. The full report made in English and called … Read the full press release
Posted in Business, Financial, Investment, News, Real Estate, Switzerland
Tagged Basel, Credit Suisse, demand, economists, Geneva, home working, Immediate outlook mixed, Lausanne, office market, office property market, office renovations, office space, real estate, real estate economists, Switzerland, Zurich
(PRESS RELEASE) ZURICH, 13-Oct-2020 — /EuropaWire/ — Credit Suisse, a global wealth manager, investment bank and financial services firm, has announced the release of its Locational Quality Indicator annual study for 2020 that looks into the locational quality of Swiss … Read the full press release
Posted in Banks, Economy, Financial, Investment, News, Switzerland
Tagged Aargau, Basel, Bern, Canton Aargau, Canton Basel-Stadt, Canton Fribourg, Canton Geneva, Canton Lucerne, Canton Valais, Canton Zug, cantonal rankings, corporate income tax, corporate taxes, Credit Suisse, Graubünde, land, locational quality, Locational Quality Indicator, Nidwalden, Schaffhausen, Schwyz, Solothurn, Swiss cantons, Swiss labor force, Swiss regions, Ticino, transport accessibility, Vaud, Zurich
EMA, MHRA and FDA among regulatory agencies participating (PRESS RELEASE) BERLIN, 10-Jun-2019 — /EuropaWire/ — The Parenteral Drug Association (PDA) is excited to host its 4th Annual European Meeting: Global Healthcare of the Present and the Future, June 25-26 in … Read the full press release
Posted in France, Germany, Healthcare, Ireland, Media, Netherlands, News, Pharma & Biotech, Science, Switzerland, United Kingdom
Tagged 4th PDA European Annual Meeting, Amsterdam, automation, Basel, Berlin, biopharmaceuticals, data quality management, data science, digitalization, Dublin, EMA, European Medicines Agency, FDA, Felix G. Rebitschek, Healthcare, HPRA, London, Manufacturing, manufacturing technologies, Max Planck Institute, medicines, MHRA, Paris, PDA, pharmaceuticals, PIC/S, regulators, Virtual Reality, Walter Morris, WHO, Zurich
BASEL, Switzerland, 23-Aug-2017 — /EuropaWire/ — Global brand leader Invacare brings next generation technology to powerchairs, following extensive trials and consumer-led insights. Touch screen technology is used daily on devices such as smartphones and tablets and thanks to Invacare, this … Read the full press release
Posted in France, Germany, Healthcare, News, Society, Switzerland, Technology, United Kingdom
Tagged Adjustable brightness, Baden-Wuttemberg, Basel, Cardiff, controls, electric wheelchairs, Fondettes, Indre et Loire, Invacare, Invacare International Sarl, Isny im Allgau, left or right handed use, LINX, Pencoed, power wheelchairs, Powerchairs, REM400, remotes, Screen lock out function, swipe operation, tap operation, technology, touch screen, touch screen technology, touchscreen, Tours, wheelchair, Wheelchairs, Witterswil
BASEL, 22-10-2015 — /EuropaWire/ — To promote consistent implementation of the Basel III countercyclical capital buffer, the Basel Committee on Banking Supervision has issued frequently asked questions and other supporting information. The information published today includes a list of all … Read the full press release
Basel, 04-6-2014 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the acquisition of Genia Technologies, Inc. (Genia), a privately held company, based in Mountain View, California, USA. Genia is developing a single-molecule, semiconductor based, DNA sequencing platform using nanopore … Read the full press release
Posted in Business, Management, Pharma & Biotech, Switzerland, Technology
Tagged Basel, Genia Technologies, nanopore technology, Roche, Roland Diggelmann, Stefan Roever
Investment to help meet rising demand for licensed biologics and expected pipeline growth Basel, Switzerland, 16-10-2013 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced plans to invest 800 million Swiss francs within its global manufacturing network to increase production … Read the full press release
Posted in Business, Germany, Healthcare, Investment, Pharma & Biotech, Switzerland
Tagged Basel, biologic medicines, Daniel O’Day, Germany, Kadcyla, licensed biologics, Oceanside, Penzberg, Perjeta, pertuzumab, RoACTEMRA, Roche, Switzerland, tocilizumab, trastuzumab emtansine, USA, Vacaville
The International Biotechnology Leadership Camp (BioCamp) fosters idea exchange with leading scientists as well as entrepreneurship for young talents 60 selected students from leading international universities attend to explore science and innovation at Novartis headquarters in Basel, Switzerland Novartis CEO … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Switzerland
Tagged Anja von Treskow, Basel, BioCamp, Eric Althoff, healthcare entrepreneur competition, International Biotechnology Leadership Camp, Isabella Zinck, Jill Pozarek, Joseph Jimenez, Novartis, Pierre-Michel Bringer, Prof. Susan Gasser, Rolf M. Zinkernagel M.D., Samir Shah, Stephen Rubino, Thomas Hungerbuehler
The UBS consumption indicator moved sideways in June. The first half of the year was weak for registrations of new cars. Zurich/Basel, 20-8-2013 — /EuropaWire/ — The UBS consumption indicator remained stable for the most part in June at 1.44 index … Read the full press release
Lucentis® (ranibizumab) is the first licensed therapy to improve vision in patients with visual impairment due to choroidal neovascularization secondary to pathologic myopia Pivotal trial shows average visual acuity improvement of up to 14 letters at one year with a median of … Read the full press release
Posted in European Union, Government, Healthcare, Pharma & Biotech, Switzerland
Tagged Basel, choroidal neovascularization, CNV, Lucentis®, Novartis, RADIANCE, Tim Wright
Recognition by the US Food and Drug Administration (FDA) that RLX030 has the potential to address a serious unmet medical need If approved, RLX030 has the potential to be the first treatment breakthrough for Acute Heart Failure patients in 20 … Read the full press release
Posted in Government, Healthcare, Pharma & Biotech, Science, Switzerland
Tagged acute heart failure, AHF, Basel, David Epstein, FDA, Novartis, RLX030, serelaxin, US Food and Drug Administration
Omalizumab met all primary and secondary endpoints in pivotal GLACIAL study of patients with refractory chronic spontaneous urticaria (CSU)[1] Omalizumab found to be effective, safe and well tolerated in refractory CSU patients, including those on antihistamines at up to four … Read the full press release
Zurich / Basel, 4-6-2013 — /europawire.eu/ — At the Annual General Meeting held on May 2, 2013, UBS’s shareholders confirmed in their offices those members of the Board of Directors who had stood for re-election, and voted Reto Francioni onto the Board … Read the full press release
Posted in Banks, Business, Financial, Management, Switzerland
Tagged Ann F. Godbehere, Annual General Meeting, Annual Report, Axel A. Weber, Axel P. Lehmann, Basel, Beatrice Weder di Mauro, Consolidated Financial Statements, David Sidwell, Ernst & Young AG, Helmut Panke, Isabelle Romy, Joseph Yam, Michel Demaré, Rainer-Marc Frey, Reto Francioni, shareholders, UBS, UBS AG, William G. Parrett, Zurich
Integrated regional sales up 8 percent at constant exchange rates Continuing momentum, growth across all regions High grower profitability supporting ongoing technology adoption Basel, Switzerland, 8-5-2013 — /europawire.eu/ — In the first quarter of 2013 integrated sales increased by 8 percent … Read the full press release
Posted in Agriculture, Business, Chemicals, Financial, Switzerland
Tagged 1Q 2013, 1Q 2013 sales, acquisitions, ACTARA, AXIAL, Basel, cereals, corn herbicide CALLISTO, corn herbicides, corn seeds, CRUISER, divestments, Garden, herbicides, Lawn, Mike Mack, SEGURIS, soybean seeds, sunflower, Syngenta, TOUCHDOWN, VIBRANCE seed care
Basel, Switzerland, 7-5-2013 — /europawire.eu/ — Syngenta acknowledged that European Union (EU) Member States for the second time failed to agree on the European Commission’s proposal for a ban on neonicotinoid pesticides. The latest decision should compel the Commission to return to … Read the full press release
Posted in Agriculture, Belgium, Business, Chemicals, European Union, Government, Law, Politics, Society, Switzerland
Tagged ban, Basel, bee health, bee health decline, disease, EFSA, health of bees, John Atkin, key crop protection technology, loss of habitat, neonicotinoid, neonicotinoid pesticides, Nutrition, Operation Pollinator initiative, Pesticides, Syngenta, viruses
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?